Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.31 |
| ▸ | KDM5A | P29375 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13078638 | 0.93 | TSHR (0.38) | TSHRALDH1A1 | |
| SCHEMBL8345906 | 0.86 | TSHR (0.50) | TSHRALDH1A1PAOXKDM5A | |
| SCHEMBL8009387 | 0.86 | TSHR (0.50) | TSHRALDH1A1PAOXKDM5A | |
| SCHEMBL6142226 | 0.84 | TSHR (0.48) | TSHRALDH1A1PAOXKDM5A | |
| SCHEMBL864676 | 0.84 | TSHR (0.52) | TSHRALDH1A1PAOX | |
| Hydrochloric Acid SCHEMBL4308486 | 0.82 | TSHR (0.50) | TSHRALDH1A1PAOX | |
| SCHEMBL1086951 | 0.82 | TSHR (0.48) | TSHRALDH1A1PAOXKDM5A | |
| SCHEMBL9301514 | 0.82 | TSHR (0.55) | TSHRALDH1A1PAOXKDM5A | |
| SCHEMBL18244864 | 0.82 | TSHR (0.55) | TSHRALDH1A1PAOX | |
| SCHEMBL11749668 | 0.80 | TSHR (0.52) | TSHRALDH1A1PAOXKDM5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100285570-A1 | FLUORIDE PROCESSING METHOD | JACKSON ALEXANDER | 2010-11-11 | — | — | US | disclosed |
| US-20100178242-A1 | LABELLING METHODS | GE HEALTHCARE LIMITED (GB) | 2010-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100285570-A1 | FLUORIDE PROCESSING METHOD | SLCO1B1, CTSF, MEN1 | TSHR 968/4885ALDH1A1 1788/4885PAOX 3258/4885 |
| US-20100178242-A1 | LABELLING METHODS | FURIN, FGF23, FGF2 | TSHR 245/4885ALDH1A1 2015/4885PAOX 3264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.